Conversely, in a recent study on the effects of a microbiome metabolite, indolepropionic acid (IPA), on PXR activation, Sari et al. (2020) showed that patients with higher expression of PXR have increased survival rates in estrogen receptor-positive cancers [57]. This evidence concerns the gene NR1I2 and cancer.